Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Stigmastanol, also known as sitostanol, is a plant stanol that has been studied for its cholesterol-lowering effects. Scientific evidence suggests that stigmastanol can reduce intestinal absorption of cholesterol, thereby lowering total blood cholesterol and LDL (low-density lipoprotein) cholesterol levels—key risk factors for cardiovascular disease (CVD). Multiple randomized controlled trials and meta-analyses have shown that daily consumption of plant stanol esters (including stigmastanol) reduces LDL cholesterol by 7-10% in both healthy individuals and those with hypercholesterolemia when used as part of a healthy diet. This cholesterol-lowering effect is the primary rationale for its use in CVD prevention and management. However, while reductions in LDL cholesterol are well-accepted surrogate markers for decreased cardiovascular risk, direct evidence from long-term outcome studies showing that stigmastanol supplementation alone reduces CVD events (such as heart attacks or strokes) is limited. Most clinical guidelines, including those from the European Atherosclerosis Society and American Heart Association, recognize plant stanols (like stigmastanol) as effective adjuncts for cholesterol lowering, but emphasize that they should not replace statins or other evidence-based therapies for high-risk patients. In summary, stigmastanol’s use for cardiovascular disease is scientifically supported for cholesterol management, but evidence is moderate and primarily limited to surrogate endpoints rather than hard clinical outcomes.

More about Stigmastanol
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Stigmastanol

Products containing Stigmastanol